{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T01:57:22Z","timestamp":1773453442607,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T00:00:00Z","timestamp":1248825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s00404-009-1185-y","type":"journal-article","created":{"date-parts":[[2009,7,28]],"date-time":"2009-07-28T11:51:11Z","timestamp":1248781871000},"page":"511-517","source":"Crossref","is-referenced-by-count":46,"title":["Prognostic significance of estrogen receptor alpha and beta expression in human serous carcinomas of the ovary"],"prefix":"10.1007","volume":"281","author":[{"given":"Alexander","family":"Burges","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ansgar","family":"Br\u00fcning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Dannenmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Blankenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo","family":"Jeschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naim","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Friese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Mylonas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,29]]},"reference":[{"issue":"2","key":"1185_CR1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.critrevonc.2006.03.004","volume":"60","author":"N Colombo","year":"2006","unstructured":"Colombo N, Van Gorp T, Parma G, Amant F, Gatta G, Sessa C, Vergote I (2006) Ovarian cancer. Crit Rev Oncol Hematol 60(2):159\u2013179","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"1185_CR2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1677\/joe.0.1750269","volume":"175","author":"KL Britt","year":"2002","unstructured":"Britt KL, Findlay JK (2002) Estrogen actions in the ovary revisited. J Endocrinol 175(2):269\u2013276","journal-title":"J Endocrinol"},{"issue":"1","key":"1185_CR3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ygyno.2004.03.026","volume":"94","author":"S Cunat","year":"2004","unstructured":"Cunat S, Hoffmann P, Pujol P (2004) Estrogens and epithelial ovarian cancer. Gynecol Oncol 94(1):25\u201332","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1185_CR4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1586\/14737140.6.1.43","volume":"6","author":"GG Rao","year":"2006","unstructured":"Rao GG, Miller DS (2006) Hormonal therapy in epithelial ovarian cancer. Expert Rev Anticancer Ther 6(1):43\u201347","journal-title":"Expert Rev Anticancer Ther"},{"issue":"3","key":"1185_CR5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1210\/er.2004-0027","volume":"26","author":"KF Koehler","year":"2005","unstructured":"Koehler KF, Helguero LA, Haldosen LA, Warner M, Gustafsson JA (2005) Reflections on the discovery and significance of estrogen receptor beta. Endocr Rev 26(3):465\u2013478","journal-title":"Endocr Rev"},{"key":"1185_CR6","doi-asserted-by":"crossref","first-page":"e003","DOI":"10.1621\/nrs.06003","volume":"6","author":"C Zhao","year":"2008","unstructured":"Zhao C, Dahlman-Wright K, Gustafsson JA (2008) Estrogen receptor beta: an overview and update. Nucl Recept Signal 6:e003","journal-title":"Nucl Recept Signal"},{"issue":"9","key":"1185_CR7","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.4161\/cbt.7.9.6427","volume":"7","author":"C Dannenmann","year":"2008","unstructured":"Dannenmann C, Shabani N, Friese K, Jeschke U, Mylonas I, Bruning A (2008) The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERbeta, and enhances expression of oncogenic cytokine GRO. Cancer Biol Ther 7(9):1460\u20131467","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"1185_CR8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/01.AOG.0000296715.07705.e9","volume":"111","author":"KK Chan","year":"2008","unstructured":"Chan KK, Wei N, Liu SS, Xiao-Yun L, Cheung AN, Ngan HY (2008) Estrogen receptor subtypes in ovarian cancer: a clinical correlation. Obstet Gynecol 111(1):144\u2013151","journal-title":"Obstet Gynecol"},{"issue":"2","key":"1185_CR9","first-page":"126","volume":"29","author":"JP Geisler","year":"2008","unstructured":"Geisler JP, Buller E, Manahan KJ (2008) Estrogen receptor alpha and beta expression in a case matched series of serous and endometrioid adenocarcinomas of the ovary. Eur J Gynaecol Oncol 29(2):126\u2013128","journal-title":"Eur J Gynaecol Oncol"},{"key":"1185_CR10","doi-asserted-by":"crossref","unstructured":"FIGO stages (announcements)1989\u2014revision. Gynecol Oncol 35:125\u2013127","DOI":"10.1016\/0090-8258(89)90027-9"},{"issue":"3","key":"1185_CR11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.acthis.2004.02.005","volume":"106","author":"I Mylonas","year":"2004","unstructured":"Mylonas I, Jeschke U, Shabani N, Kuhn C, Balle A, Kriegel S, Kupka MS, Friese K (2004) Immunohistochemical analysis of estrogen receptor alpha, estrogen receptor beta and progesterone receptor in normal human endometrium. Acta Histochem 106(3):245\u2013252","journal-title":"Acta Histochem"},{"issue":"3A","key":"1185_CR12","first-page":"1679","volume":"25","author":"I Mylonas","year":"2005","unstructured":"Mylonas I, Jeschke U, Shabani N, Kuhn C, Kriegel S, Kupka MS, Friese K (2005) Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR). Anticancer Res 25(3A):1679\u20131686","journal-title":"Anticancer Res"},{"issue":"2","key":"1185_CR13","first-page":"169","volume":"22","author":"I Mylonas","year":"2007","unstructured":"Mylonas I, Jeschke U, Shabani N, Kuhn C, Kunze S, Dian D, Friedl C, Kupka MS, Friese K (2007) Steroid receptors ERalpha, ERbeta, PR-A and PR-B are differentially expressed in normal and atrophic human endometrium. Histol Histopathol 22(2):169\u2013176","journal-title":"Histol Histopathol"},{"issue":"16","key":"1185_CR14","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.ejca.2007.08.014","volume":"43","author":"N Shabani","year":"2007","unstructured":"Shabani N, Kuhn C, Kunze S, Schulze S, Mayr D, Dian D, Gingelmaier A, Schindlbeck C, Willgeroth F, Sommer H et al (2007) Prognostic significance of oestrogen receptor alpha (ERalpha) and beta (ERbeta), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas. Eur J Cancer 43(16):2434\u20132444","journal-title":"Eur J Cancer"},{"key":"1185_CR15","first-page":"138","volume":"8","author":"W Remmele","year":"1987","unstructured":"Remmele W, Stegner HE (1987) Vorschlag zur einheitlichen Definierung eines immunreaktiven Score (IRS) f\u00fcr den immunhistochemischen \u00d6strogenrezeptornachweis (ER-ICA) im Mammakarzinomgewebe. Pathologe 8:138\u2013140","journal-title":"Pathologe"},{"key":"1185_CR16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"1185_CR17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR (1972) Regression models and life tables. J R Stat Soc B 34:187\u2013220","journal-title":"J R Stat Soc B"},{"issue":"4","key":"1185_CR18","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1677\/erc.1.01039","volume":"12","author":"AJ O\u2019Donnell","year":"2005","unstructured":"O\u2019Donnell AJ, Macleod KG, Burns DJ, Smyth JF, Langdon SP (2005) Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen. Endocr Relat Cancer 12(4):851\u2013866","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"1185_CR19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.canlet.2005.01.021","volume":"231","author":"G Lazennec","year":"2006","unstructured":"Lazennec G (2006) Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis. Cancer Lett 231(2):151\u2013157","journal-title":"Cancer Lett"},{"issue":"3","key":"1185_CR20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1677\/JOE-07-0087","volume":"193","author":"O Treeck","year":"2007","unstructured":"Treeck O, Pfeiler G, Mitter D, Lattrich C, Piendl G, Ortmann O (2007) Estrogen receptor {beta}1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells. J Endocrinol 193(3):421\u2013433","journal-title":"J Endocrinol"},{"issue":"4","key":"1185_CR21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/pgp.0b013e31803025cd","volume":"26","author":"KK Wong","year":"2007","unstructured":"Wong KK, Lu KH, Malpica A, Bodurka DC, Shvartsman HS, Schmandt RE, Thornton AD, Deavers MT, Silva EG, Gershenson DM (2007) Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis. Int J Gynecol Pathol 26(4):404\u2013409","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"1185_CR22","first-page":"1051","volume":"18","author":"EV Hogdall","year":"2007","unstructured":"Hogdall EV, Christensen L, Hogdall CK, Blaakaer J, Gayther S, Jacobs IJ, Christensen IJ, Kjaer SK (2007) Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the \u2018MALOVA\u2019 ovarian cancer study. Oncol Rep 18(5):1051\u20131059","journal-title":"Oncol Rep"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-009-1185-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-009-1185-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-009-1185-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T14:05:37Z","timestamp":1739282737000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-009-1185-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,29]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["1185"],"URL":"https:\/\/doi.org\/10.1007\/s00404-009-1185-y","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,29]]}}}